Search

Search Constraints

You searched for: Author/Creator Bambury, Richard

Search Results

2. HER2 as a target in invasive urothelial carcinoma. (26th February 2015)

4. Pembrolizumab alone or combined with chemotherapy versus chemotherapy as first-line therapy for advanced urothelial carcinoma (KEYNOTE-361): a randomised, open-label, phase 3 trial. Issue 7 (July 2021)